Prevail Therapeutics
Clinical trials sponsored by Prevail Therapeutics, explained in plain language.
Now part of
Eli Lilly and Company
LLY
NYSE
A gene therapy company developing treatments for neurodegenerative diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Gene therapy injection aims to halt fatal brain disease in babies Results expected Feb 2027 (estimated)